{"entity":{"type":"insider","cik":"0001490476","url":"/insider/0001490476","json_url":"/insider/0001490476.json","name":"Kellen Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2013-08-12","last":"2023-06-26","span_basis":"filed_date"},"name_variants":[{"name":"Kellen Scott","source":"filing","n_filings":10,"first_seen":"2013-08-12","last_seen":"2023-06-26"}],"transactions":[{"id":7957054,"accession":"0001235802-23-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-23-000070","line_url":"/filing/0001235802-23-000070#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":39100.0,"total_display":"39,100.00","shares_owned_after":32290.0,"shares_owned_after_display":"32,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":4116668,"accession":"0001235802-21-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-21-000097","line_url":"/filing/0001235802-21-000097#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.1463,"price_display":"3.15","price_state":"stated","total_value":31463.0,"total_display":"31,463.00","shares_owned_after":22290.0,"shares_owned_after_display":"22,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-16","scope":"insider"},{"id":2090786,"accession":"0001235802-20-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-20-000122","line_url":"/filing/0001235802-20-000122#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.1933,"price_display":"4.19","price_state":"stated","total_value":8386.6,"total_display":"8,386.60","shares_owned_after":12290.0,"shares_owned_after_display":"12,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":7794055,"accession":"0001235802-19-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-19-000108","line_url":"/filing/0001235802-19-000108#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.43,"price_display":"2.43","price_state":"stated","total_value":7290.0,"total_display":"7,290.00","shares_owned_after":10290.0,"shares_owned_after_display":"10,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-19","scope":"insider"},{"id":7847263,"accession":"0001235802-19-000044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-19-000044","line_url":"/filing/0001235802-19-000044#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.9425,"price_display":"2.94","price_state":"stated","total_value":11770.0,"total_display":"11,770.00","shares_owned_after":7290.0,"shares_owned_after_display":"7,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-24","filed_date":"2019-05-28","scope":"insider"},{"id":6665057,"accession":"0001235802-18-000180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-18-000180","line_url":"/filing/0001235802-18-000180#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (CFO and Secretary)","officer_title":"CFO and Secretary","security_title":"Voting Common Shares, no par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","shares_owned_after":3290.0,"shares_owned_after_display":"3,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-11","scope":"insider"},{"id":6027858,"accession":"0001437749-18-003127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-18-003127","line_url":"/filing/0001437749-18-003127#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-20","filed_date":"2018-02-22","scope":"insider"},{"id":3336968,"accession":"0001437749-16-034507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-16-034507","line_url":"/filing/0001437749-16-034507#line-1","is_derivative":false,"issuer_cik":"0001029125","issuer_name":"Sun BioPharma, Inc.","issuer_ticker":"SNBP","issuer_name_source":null,"issuer_url":"/issuer/0001029125","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider"},{"id":4490753,"accession":"0001235802-13-000103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001235802-13-000103","line_url":"/filing/0001235802-13-000103#line-2","is_derivative":false,"issuer_cik":"0001460198","issuer_name":"Kips Bay Medical, Inc.","issuer_ticker":"KIPS","issuer_name_source":null,"issuer_url":"/issuer/0001460198","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (COO, CFO, VP of Finance & Secy)","officer_title":"COO, CFO, VP of Finance & Secy","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6900.0,"shares_display":"6,900","price_per_share":0.78,"price_display":"0.78","price_state":"stated","total_value":5382.0,"total_display":"5,382.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-30","filed_date":"2013-09-03","scope":"insider"},{"id":4490749,"accession":"0001235802-13-000103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-13-000103","line_url":"/filing/0001235802-13-000103#line-1","is_derivative":false,"issuer_cik":"0001460198","issuer_name":"Kips Bay Medical, Inc.","issuer_ticker":"KIPS","issuer_name_source":null,"issuer_url":"/issuer/0001460198","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (COO, CFO, VP of Finance & Secy)","officer_title":"COO, CFO, VP of Finance & Secy","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3100.0,"shares_display":"3,100","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":2387.0,"total_display":"2,387.00","shares_owned_after":13100.0,"shares_owned_after_display":"13,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-30","filed_date":"2013-09-03","scope":"insider"},{"id":5544483,"accession":"0001235802-13-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001235802-13-000084","line_url":"/filing/0001235802-13-000084#line-1","is_derivative":false,"issuer_cik":"0001460198","issuer_name":"Kips Bay Medical, Inc.","issuer_ticker":"KIPS","issuer_name_source":null,"issuer_url":"/issuer/0001460198","owner_cik":"0001490476","owner_name":"Kellen Scott","owner_url":"/insider/0001490476","role":"Officer (COO, CFO, VP of Finance & Secy)","officer_title":"COO, CFO, VP of Finance & Secy","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":8200.0,"total_display":"8,200.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-12","filed_date":"2013-08-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401040","name":"DiaMedica Therapeutics Inc.","url":"/issuer/0001401040","role":"Officer (CFO and Secretary)","n_filings":6,"first_seen":"2018-12-11","last_seen":"2023-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001029125","name":"Sun BioPharma, Inc.","url":"/issuer/0001029125","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2016-06-28","last_seen":"2018-02-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001460198","name":"Kips Bay Medical, Inc.","url":"/issuer/0001460198","role":"Officer (COO, CFO, VP of Finance & Secy)","n_filings":2,"first_seen":"2013-08-12","last_seen":"2013-09-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001490476","retrieved_at":"2026-08-21T22:29:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}